Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON54897Phase 4Not yet recruiting
A Phase 4 trial of bleomycin in keloid, sponsored by Erasmus MC. Planned start May 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON54897.